Skip to content
Search

Latest Stories

Pharmacies can become frontline educators of self-care

Kenvue’s Bas Vorsteveld advocates for integrating self-care into the government’s 10-year health plan and empowering pharmacy teams to take on a greater role in preventative healthcare.

Pharmacies key to driving the shift from treatment to prevention

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe.

Pharmacies have the potential to play a pivotal role in the government's transition from treatment-based healthcare to a more prevention-focused approach. However, for this shift to be successful, they require greater systemic support.

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe, emphasises the importance of allowing pharmacists access to patient records to enable them to offer tailored advice and improve patient care.


“Through targeted initiatives and partnerships within existing frameworks such as Pharmacy First, pharmacists can play an even greater role in supporting individuals to manage minor health concerns independently,” he told Pharmacy Business.

“This extends beyond simply dispensing medications – providing invaluable and accessible medical advice.”

Bas acknowledges the increasing strain UK pharmacists face, including growing workloads and the demands of expanding clinical roles.

“As their role continues to expand, allowing access to patient records, through the existing NHS app, for example, would enable more personalised advice and proactive care,” he said.

“They could help consumers manage common conditions more effectively, reducing the need for GP appointments and relieving pressure on services.”

Bas noted that Kenvue is committed to supporting this transformation through initiatives such as the Pharmacist Leaders Forum, which brings together key stakeholders and industry leaders to explore ways to better support and leverage pharmacists' expertise to enhance patient outcomes.

Pharmacies’ role in preventative care

While pharmacy teams are commonly consulted for concerns like coughs and digestive health issues, Bas highlighted that there's an opportunity to build on personalised discussions around preventative care, like smoking cessation and wider wellness strategies.

“Kenvue is well placed to support these preventative efforts,” he said.

“For example, through NICORETTE®, which has pioneered nicotine replacement therapy innovation and quitter support for over 40 years. The brand is still innovating with NICORETTE® QuickMist, which was the first licensed vaping cessation therapy in the UK to help people achieve a total quit from tobacco and nicotine.”

Although pharmacists are confident addressing a wide range of health issues, a recent survey by the company found they can still feel “uncertain” in specific areas, including oral health and skin concerns.

Bas stressed that targeted training could enhance existing self-care resources and reaffirmed Kenvue’s commitment to empowering pharmacy teams through various support initiatives.

The company is set to launch Kenvue Professionals – an online hub providing educational resources for UK healthcare professionals (HCPs), including pharmacy teams, to support their expanding clinical roles – later this year.

“Our aim is to offer easy-to-access evidence-based information on common conditions and ailments while keeping HCPs updated on our latest brand developments,” he explained.

“We are in discussion with pharmacists to ensure the portal provides the most helpful resources, support and recognition they need to enhance their ability to deliver self-care and other preventative solutions.”

Worryingly, the Kenvue survey revealed that 97% of pharmacists are helping to fill gaps in GP services, yet 63% report struggling with unsustainable workloads, highlighting the need for better support.

“The public’s understanding of a pharmacy team’s role needs to evolve, recognising their expanding role in community care and prevention, and for this to succeed,” Bas noted.

Self-care: A key pillar of preventative healthcare

Self-care is a fundamental component of the shift from treatment to prevention, according to Bas.

“We need to break the habit of reactive care,” he said, noting that self-care is “one of the most promising and exciting approaches” to improve the health and wellbeing of the nation.

He strongly supports integrating self-care into the government’s 10-year health plan, recognising it as a foundation for improved outcomes and a more sustainable healthcare system.

“Ensuring the success of the recent reforms announced by the government - to recentralise the responsibilities of NHS England within the Department for Health and Social Care - will be critical.

“If done right, these reforms have the potential to accelerate the shift from treatment to prevention that the government is aiming for, and self-care can play a huge part in that.”

Bas also welcomed the government’s Tobacco and Vapes Bill, calling for its swift passage to protect future generations from tobacco-related harms.

“Smoking remains the leading cause of preventable death and disease, and we believe it is critical that smokers receive the support they need to quit,” he said.

“The government should now also focus on ensuring that smokers have access to a broad range of therapeutic medicines, such as Nicotine Replacement Therapies, alongside evidence-based services to support their quit journey.”

Oral health is expected to be one of the preventative measures emphasised in the plan.

Bas highlighted that poor oral hygiene, particularly periodontal disease, can be associated with chronic conditions such as heart disease and diabetes.

“As people take a more proactive role in their wellbeing, incorporating a complete oral care routine becomes essential,” he said.

“More comprehensive government policies and recommendations encouraging complete oral health routines can have lasting, impactful results.”

Pharmacies as frontline educators of self-care

Empowering individuals to practise everyday moments of self-care remains a largely untapped healthcare resource, according to Bas.

Additionally, barriers such as limited awareness, access to products and lack of trust persist.

“People often hesitate to take control of their health because they’re overwhelmed by conflicting information,” he explained.

“As an industry, we must collaborate with HCPs to improve health literacy so people understand how self-care can help them take charge of their health.”

Pharmacies, he added, are ideally positioned to become the “frontline educators of self-care”, providing trusted advice on managing common conditions.

“For example, many people think they need antibiotics for colds, coughs, or RSV, driving up antibiotic resistance, even though these upper respiratory conditions are often viral, not bacterial, meaning antibiotics are ineffective.

“In these situations, self-care products and OTC medicines, such as SUDAFED®, BENYLIN® and other products like ZARBEES® can offer effective symptomatic control while the body’s own immune system eliminates the virus.”

The Kenvue survey found that 87% of pharmacists believe better self-care practices could prevent many health issues, with 80% stating that improved consumer education would make a significant impact.

Bas urged the government to develop “a national health literacy blueprint” and build partnerships with key stakeholders, including the private sector, to promote this.

The role of technology in promoting self-care

Looking ahead, digital health tools will play an increasingly vital role in empowering individuals to manage their health before issues arise—a focus likely to be included in the government’s 10-year plan.

“AI is an addition, not a replacement,” Bas clarified.

“In light of the significant amount of care that will be required to manage the aging population in the next 10 to 15 years, it’s been recognised that there is an important role for digital technologies in helping people to be more involved in the self-management of their health.”

Kenvue is already integrating digital solutions in its offerings to empower people to make informed health choices and manage their conditions more efficiently.

For example, their IMODIUM® Gut2Know™ app helps diarrhoea sufferers track their gut health and identify symptom triggers, and the NICORETTE® Stop Smoke & Vape app allows consumers to create a tailored quit plan and track progress.

“It’s about providing encouragement and advice at the right moments to keep people motivated - personalised, digital experiences that integrate naturally into their lives,” he added.

With the right support—through policy changes, public education, and digital innovation—pharmacy teams can become leading providers of self-care and preventative health solutions.

More For You

How community pharmacies can safely and profitably deliver high-quality NHS and private services

L-R: Baba Akomolafe, Rachna Chhatralia, Patricia Tigenoah-Ojo, and Raj Matharu

How community pharmacies are optimising services for a sustainable future

“Community pharmacy has come to a point where we have to change ourselves,” said Raj Matharu, CEO at Community Pharmacy South East London, and Superintendent Pharmacist of Westchem Pharmacy, as he opened a panel discussion at the recent Pharmacy Business Conference.

The 'Optimising Service Opportunities' session centred on how community pharmacies can safely and profitably deliver high-quality NHS and private services, while ensuring an excellent patient experience.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Janet Morrison discusses pharmacy funding strategy at 2025 conference

Health Secretary Wes Streeting outlines government support for community pharmacy

CPE calls new funding deal a ‘reluctant yes’

Community Pharmacy England (CPE) was “reluctant” to accept the new pharmacy funding deal due to the significant funding gap, said the organisation’s chief executive Janet Morrison, while recognising the settlement as the first step towards stabilising the sector.

Addressing the 2025 Pharmacy Business Conference on Sunday at London Hilton Wembley, Janet shared insights into the behind-the-scenes work that led to the agreement.

Keep ReadingShow less